SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit is drawing attention ahead of the FDAs PDUFA decision on ivonescimab for EGFR-mutated lung cancer, with traders treating the outcome as a binary catalyst. The debate centers on the FDAs stated need for statistically significant overall-survival evidence versus the drugs PFS benefit and favorable survival trend; some see a path to approval, while others fear a CRL, and the recent selloff has fueled speculation about a negative outcome without confirming one.

American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Domestic, Latin America, Atlantic, and Pacific. The company was founded on December 9, 2013, and is headquartered in Fort Worth, TX.

American Airlines Group Inc

A nationwide FAA ground stop after an air-traffic-control communications failure is weighing on airline shares, including American. Traders are reacting to the operational disruption and debating its cause, with cyberattack and other explanations remaining speculation.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

A nationwide FAA ground stop tied to an air-traffic-control communications failure has put Delta and other airline stocks in focus. Traders are weighing the operational and market impact, with some speculating about a cyber or AI connection, though the cause has not been confirmed.

United Airlines Holdings, Inc. is a holding company, which engages in the provision of transportation services. It operates through the following geographical segments: Domestic, Atlantic, Pacific, and Latin America. The company was founded on December 30, 1968 and is headquartered in Chicago, IL.

United Airlines Holdings Inc

A rare FAA nationwide ground stop halting U.S. departures after an air-traffic-control communications failure is weighing on United and other airline shares. Traders are debating whether the disruption will persist and speculating about its cause, including cyber or AI involvement, but those explanations remain unconfirmed; some view the pullback as a buying opportunity.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Upstarts Q3 growth and earnings beat have failed to reverse its steep slide to fresh lows, as traders focus on cautious guidance, debt and funding exposure, and sensitivity to high rates and borrower credit risk. Bulls cite CEO share purchases, improving results, and a potential bank charter, while skeptics warn that credit and funding risks could outweigh those positives; bankruptcy claims remain speculation.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

Starship Flight 15s attempted double recovery is driving attention: traders say the booster was not caught and landed in the Gulf, while the upper-stage recovery attempt remains a focus. Reactions are split between calling the booster outcome a failure and viewing the safe landing or decision to prioritize safety as progress.

Almonty Industries, Inc. engages in the mining, processing, and shipment of tungsten concentrates. Its projects include Almonty Korea Tungsten, Panasquiera mine, Gentung, Almonty Korea Moly, Los Santos mine, and Valtreixal. The company was founded on September 28, 2009 and is headquartered in Dillon, MT.

Almonty Industries Inc

Almontys Sangdong tungsten mine moving into commercial production and ramping up is the main focus, with traders watching for evidence of sustained output and revenue. Bulls point to tight tungsten supply, rising prices and demand for non-Chinese sources, while skeptics remain concerned about execution and want to see operating results.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A sharp after-hours QQQ selloff drew attention after a nationwide FAA ground stop tied to communications problems; traders debated cyberattack or AI-related speculation versus an ordinary technical failure and market overreaction. Ongoing pressure on technology and semiconductor shares, alongside uncertainty around Nvidias leadership, added to concerns about the broader AI trade.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

NTLA is drawing attention after a sharp decline that traders say lacks a new company-specific catalyst; explanations range from a broader selloff in speculative stocks and weak bids to short-selling and stop-loss activity. The debate contrasts the price weakness with previously reported Lonvo-Z HAE data and its pending FDA review, with some traders viewing the drop as unjustified and others remaining bearish on the stock.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebiuss selloff is drawing attention after its outlook raised concerns about delayed data-center capacity coming online and a near-term slowdown, alongside weakness across AI and neocloud stocks. Bears worry about execution, financing and Nvidia-related uncertainty, while bulls argue demand remains strong and the delays are temporary.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sunlink Health Systems provides healthcare investments in markets such as healthcare facilities, specialty pharmacies, and corporations. They provide retail pharmacy products and services, institutional pharmacy services, specialty pharmacy services, and durable medical equipment services.

Sunlink Health Systems Inc

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

SSY News